Simcere Pharmaceutical Group Limited 先聲藥業集團有限公司

Pay for financial year ended 2022-12-31

Source: Annual report

Note: while most data are extracted from annual reports, some data in these tables may have been taken from supplemental filings made in response to complaints to SEHK by our volunteer editors. Please report any errors.

Name Last
position
Fees Salary &
benefits
Bonus Retire Share-
based
Total

CNY '000

Directors

1 Ren, Jinsheng 任晉生 Ch, CEO, Fdr 2,044 781 65 2,890
2 Song, Rui Lin 宋瑞霖 INED 360 360
3 Tang, Renhong 唐任宏 ED 2,842 10,555 39 6,791 20,227
4 Wan, Yushan 萬玉山 FD 1,282 5,595 39 4,339 11,255
5 Wang, Jianguo (Huitongda) 汪建國 INED 360 360
6 Wang, Xinhua (1955) 王新華 INED 360 360
7 Zhao, John Huan 趙令歡 NED
Total 1,080 6,168 16,931 143 11,130 35,452

Main board pay history

Click on the year-end to see the pay details.

CNY'000

Year-end Fees Salary &
benefits
Bonus Retire Share-
based
Total
2024-12-31 1,440 11,740 3,323 217 50,820 67,540 Report
2023-12-31 1,440 11,602 13,532 183 7,327 34,084 Report
2022-12-31 1,080 6,168 16,931 143 11,130 35,452 Report
2021-12-31 1,080 5,463 4,886 92 10,205 21,726 Report
2020-12-31 1,080 7,702 7,384 96 7,461 23,723 Report
Total 6,120 42,675 46,056 731 86,943 182,525

Want to see more years here? volunteer to be a Webb-site editor and add the data from annual reports!


Sign up for our free newsletter

Recommend Webb-site to a friend

Copyright & disclaimer, Privacy policy

Back to top